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The classic and simple story of β-AR-induced cardiac inotropy that we typically teach students (depending on the level) is as follows. β-AR stimulation by norepinephrine or epinephrine stimulates G s -dependent activation of adenylyl cyclase, which produces cAMP that activates PKA to phosphorylate key target proteins in excitation-contraction coupling. Key functional targets that we discuss are the L-type Ca channel, phospholamban (PLN), and troponin I (TnI). 2 Sometimes we also include myosin-binding protein C, the ryanodine receptor, phospholemman (that modulates the Na/K-ATPase akin to PLN regulation of the sarcoplasmic reticulum [SR] Ca-ATPase [SERCA]), delayed rectifier K + channels (I Kr and I Ks ), and Cl − channels (I CFTR and I Cl(Ca) ). 3 So even from the simple β-ARcAMP-PKA pathway, there are many targets that produce meaningful functional effects in the integrated β-AR fight-orflight response. But, based on our recent analysis, 3 the main targets likely to contribute quantitatively to β-AR-and PKAinduced inotropy and lusitropy are L-type Ca channel, PLN, phospholemman, I Ks , TnI, and myosin-binding protein C. My own simple functional model is that (1) the L-type Ca channel and PLN/SERCA effects elevate cellular and SR Ca 2+ content, which causes a major increase in Ca transient amplitude, (2) phospholemman and I Ks effects temper the rise in myocyte Ca 2+ by enhancing Na + extrusion via the Na pump and limiting action potential duration, respectively, (3) PLN/SERCA and TnI mediate lusitropy by accelerating [Ca 2+ ] i decline and Ca 2+ dissociation from the myofilaments, respectively, and (4) myosinbinding protein C enhances myofilament cross-bridge cycling and thus compensates for the intrinsically negative inotropic effect of reduced myofilament Ca 2+ sensitivity mediated by TnI phosphorylation. Not all of these points are fully resolved, but this seems complicated enough, without thinking about NOS involvement! But such is the complex beauty of biology.
There is compelling evidence that β-AR signaling activates other pathways in parallel to PKA, including NOS1 and NOS3, to produce nitric oxide that can activate soluble guanylyl cyclase and protein kinase G, but can also cause direct S-nitrosylation of many proteins in heart. 1,4-7 β-AR-induced cAMP also activates Epac (exchange protein activated by cAMP), which can activate Ca-Calmodulin-dependent protein kinase (CaMKII) to phosphorylate ryanodine receptor and promote arrhythmogenic SR Ca 2+ leak. 8 β-AR stimulation can also activate CaMKII via a PKA-independent and NOS1-dependent pathway and promote ryanodine receptor gating, 9-11 and we now know that cardiac CaMKIIδ can be directly nitrosylated at specific sites, which either promote or inhibit CaMKIIδ activity. 12 Given the importance of CaMKII in pathological signaling in the heart, 13 this nidus of β-AR, NOS, and CaMKII signaling will be critical to unravel.
What's New and Exciting Here
The novel data of Irie et al 1 show that NOS works in concert with PKA at 2 of the main PKA targets (PLN and troponin) by a unique set of molecular mechanisms during β-AR-induced cardiac inotropy. They use transgenic overexpression of S-nitrosoglutathione reductase (GSNOR), which causes protein denitrosylation.
14 Note that this enzyme is not expected to prevent NO effects mediated by cGMP or protein kinase G. Their Figure 1 shows the traditional isoproterenol (ISO)-induced increase in Ca transient and contraction amplitude in wild-type mice and that the contraction effect is preserved in the GSNOR-TG. However, in GSNOR-TG mice, the increased Ca transients was strikingly absent. This raised 2 questions for the GSNOR-TG: (1) why didn't ISO increase Ca transients and (2) how did ISO increase contraction without a rise in Ca transients? The mechanisms they uncovered are intriguing.
Ca Handling
Regarding Ca transients, the ISO-induced enhancement of Ca current and PLN phosphorylation were normal in the GSNOR-TG, but the normal rise in SR Ca content was absent. So a failure of SR Ca content to rise largely explains the lack of ISO-induced Ca transient enhancement. They attribute this failure of SR Ca loading to a lack of ISO-induced PLN pentamerization (on gels). They further show that S-nitrosylation of PLN at 2 transmembrane cysteines (C36 and C41, but not C46) is critical for pentamer formation in gels and SERCA disinhibition when mutant PLN is expressed in PLN knockout myocytes. The idea is that even when PLN is phosphorylated
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by PKA at S16, S-nitrosylation of PLN-C36 and C41 is required for PLN to form stable pentamers on the gel and for the disinhibition or activation of SERCA function. This is a nice explanation and raises some new ideas about how PKA and S-nitrosylation may need to work together in the regulation of PLN pentamerization and regulation of SERCA function. However, for quantitative Ca-handling aficionados like me, there are some questions that will need to be resolved to fully understand these interesting results mechanistically. First, if in the GSNOR-TG ISO is unable to activate SERCA, why was the most direct readout of SERCA function in intact mouse myocytes (tau of twitch [Ca] i decline) 15 still identically responsive to ISO in the GSNOR-TG (going from ≈90 to 50 ms; Online Figure VIIB) ? That would imply that the measured PLN phosphorylation ( Figure 4C ) was sufficient to stimulate SERCA function in these myocytes, despite the measured prevention of PLN S-nitrosylation ( Figure 3A ). Coupling that with the normal ISO-induced Ca current increase (Online Figure V) , the suppression of ISO-induced SR Ca leak, and the reduced fractional SR Ca release ( Figure 4A ), ISO should still increase SR Ca content substantially, but it did not. The only measure that goes in the right direction to limit the rise in SR Ca content is the ISO-induced enhancement of Na/Ca exchange (NCX) function, which was unique to GSNOR-TG mice. It seems to me possible, but surprising, that the enhanced NCX function might explain the prevention of SR Ca content to rise in the GSNOR-TG. The authors also suggest that this ISO-induced NCX enhancement might make up for the lack of ISO-induced SERCA function during twitch [Ca] ) much as we find in mouse in detailed quantitative analysis. 15 For an NCX increase to pick up the slack for a missing PLN-SERCA component in ISO-induced acceleration of [Ca] i decline would require ≈10 times larger increase in NCX function than they observed.
A second point regards their novel observation that S-nitrosylation at C36 and C41 is obligate for PLN pentameriation on gels. The data seem clear, but it is probably not an absolute requirement because prior work showed that purified PLN can pentamerize in liposomes where PLN S-nitrosylation is not expected 16 and that C36A and C41A cause reduction (not abolition) of the percent of PLN in pentamers. 17 Nevertheless, the new observations here that S-nitrosylation at these sites may importantly modulate the PLN-dependent regulation of SERCA suggests that further study should occur to resolve the mechanistic details.
Myofilament Effects
Regarding contraction, the loss of S-nitrosylation on troponin C (TnC) at C84 in GSNOR-TG seems to prevent the normal ISOinduced decrease in myofilament Ca sensitivity, despite a retained phosphorylation of TnI at the well-known S23/S24 sites. Not only was that classic myofilament desensitization gone without ISO-induced C84 S-nitrosylation, but their data suggest that in the GSNOR-TG or with C84S TnC in wild-type mice, ISO enhances myofilament Ca sensitivity. That could indeed explain how the ISO-induced inotropy is maintained without an increase in Ca transient amplitude. It also raises some exciting new fundamental questions about the molecular mechanism by which TnI, upon PKA-dependent phosphorylation at known serines, transmits that information to TnC. That transmission is thought to cause reduced Ca affinity of TnC that contributes to the lusitropic effect of β-AR stimulation. 18 These troponin-related experiments also set the scene for additional studies to further understand the mechanistic details of the effects uncovered by the insightful and clever studies by Irie et al. 1 For example, the data on myofilament Ca sensitivity are somewhat indirect, and it would be valuable to know how PKA modifies classical myofilament Ca sensitivity curves in the absence of TnC-C84 S-nitrosylation. That is, does PKA produce a parallel shift to higher Ca sensitivity or does it change the steepness of force-[Ca] relationship? Because the normal myofilament Ca desensitization caused by PKA phosphorylation is thought to be part of the lusitropic effect of β-AR stimulation, reversing this effect in GSNOR-TG or with expression of C84S TnC would be expected to diminish the lusitropic effect of ISO. However, both the lusitropic and [Ca] i decline acceleration were maintained in those experiments ( Figure 6D -6E and Online Figure IX) . One potential explanation is that SERCA predominates strongly over troponin in the lusitropic effect of ISO, which we found to be especially true for myocyte relaxation without mechanical load 19 (the type of contractions studied by Irie et al 1 ). The other possibility is that the mechanism by which TnI phosphorylation alters myofilament Ca sensitivity in the absence of C84 S-nitrosylation is different from a simple shift in the force-[Ca] relationship to lower [Ca] , such that relaxation is not retarded.
Hypertrophy and Heart Failure
Another novel observation here was that GSNOR-TG mice did not show calcineurin activation during ISO-induced inotropy (consistent with the lack of Ca transient increase). Calcineurin is a Ca-calmodulin-activated phosphatase known to be an important mediator in Ca signaling and transcription in hypertrophy and heart failure. 20 Moreover, the GSNOR-TG mice were also protected from calcineurin activation, hypertrophy, and heart failure during chronic ISO infusion. This raises the idea that preventing S-nitrosylation of key Ca handling or contractile proteins could be beneficial in mitigating progression of heart failure, while maintaining the ability of β-AR signaling to increase Ca current and contraction.
The article by Irie et al 1 opens up exciting new areas from fundamental mechanisms of PLN-SERCA and myofilament regulation to potential novel therapeutic approaches for the treatment of heart failure and arrhythmias. I found this article exciting and hope that future studies will help to flesh out some of the mechanistic details that underlie these mechanistically interesting observations.
